Summary
61 / 100 · Bulios Score
What speaks for it
- It earns 16 INR a year on every 100 INR of invested capital.
- It holds more cash than debt: ₹100.4M against ₹14.4M.
- Out of every 100 INR of revenue, 8.1 INR is left as net profit.
What to watch
- Revenue fell by 7.0% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 18.3 INR for 1 INR of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (INR)
Diluted EPS (INR)
- Analyst estimate
Revenue grew by 1.1% a year over 5 years. Over the last 3 years it fell by 7.0% a year. Earnings per share fell by 13% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 INR of revenue goes
- Cost of sales 78 INR
- Sales and administration 11 INR
- Taxes and other 2.4 INR
- Net profit 8.1 INR
Net profit, industry median (Chemicals - Specialty) 6.1 INR
Out of every 100 INR of revenue, 8.1 INR is left as net profit.
Profitability in detailIs it financially healthy?
YesIt holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Moderate, at risk- Yield
- 3.16%
- Paid out of profit
- 58%
You receive ₹3.25 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail